MedTrace Logo

Randomized Controlled Trial of Conventional vs Theta Burst rTMS

NCT01887782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 414

Last updated 2017-01-30

No results posted yet for this study

Summary

This trial will compare a novel form of rTMS, intermittent Theta Burst Stimulation to the standard conventional high frequency left sided stimulation protocol. The Left dorsolateral prefrontal cortex will be the site of stimulation in both treatment conditions. The site of stimulation will be targeted using MRI co-registration. The study seeks to determine if the two treatment protocols have similar effectiveness in treating major depression.

Conditions

Interventions

DEVICE

HFL rTMS

Magventure Cool B70 Coil with either RX100 or RX30 Stimulator

DEVICE

iTBS

Magventure Cool B70 Coil with either RX100 or RX30 Stimulator

Sponsors & Collaborators

  • University Health Network, Toronto

    collaborator OTHER

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Daniel Blumberger, MD, MSc · Centre for Addiction and Mental Health

  • Jonathan Downar, MD, PhD · University Health Network, Toronto Western Hospital

  • Fidel Vila-Rodriguez, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-07-31
Completion
2016-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01887782 on ClinicalTrials.gov